SUMMARYTwo related outbreaks (in 2009 and 2012) of cryptosporidiosis in Norwegian schoolchildren
during a stay at a remote holiday farm provided us with a natural experiment to
investigate possible secondary transmission of Cryptosporidium parvum IIa
A19G1R1. After the children had returned home, clinical data and stool samples were
obtained from their household contacts. Samples were investigated for the presence of
Cryptosporidium oocysts by immunofluorescence antibody test. We found
both asymptomatic and symptomatic infections, which are likely to have been secondary
transmission. Laboratory-confirmed transmission rate was 17% [4/23, 95% confidence
interval (CI) 7·0–37·1] in the 2009 outbreak, and 0% (95% CI 0–16·8) in the 2012 outbreak.
Using a clinical definition, the probable secondary transmission rate in the 2012 outbreak
was 8% (7/83, 95% CI 4·1–16·4). These findings highlight the importance of hygienic and
public health measures during outbreaks or individual cases of cryptosporidiosis. We
discuss our findings in light of previous studies reporting varying secondary transmission
rates of Cryptosporidium spp.
Although Cryptosporidium is seldom considered as an aetiological agent of gastrointestinal illness in Norway, this outbreak indicates that it should not be excluded. In this cryptosporidiosis outbreak, the largest in Norway to date, the transmission vehicle was not definitively identified, but a food handler, water, and animal contact could not be excluded. We recommend improving hand hygiene routines, boiling drinking water, and emphasise that people who are unwell, particularly those working in catering, should stay away from work.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.